Chelidonine is the major alkaloid component of Chelidonium majus. Chelidonium majus L. is the only species of the tribe Chelidonieae of the family Papaveraceae. Papaveraceae is rich in specific alkaloids. C. majus contains various isoquinoline alkaloids with protopine, protoberberine and benzophenanthridine structures. This benzophenanthridine alkaloid can induce apoptosis in some transformed or malignant cell lines. D-Chelidonine, the main alkaloid of Chelidonium majus, was first isolated in 1839. The supposed healing properties of greater celandine were believed in throughout Europe and Asia during the Emperial Roman period, and New Worldaboriginal cultures used BIA-containing plants by using sap or root extracts to treat minor cuts and infections.
Synthesis
The amide was heated in boiling bromobenzene to form the transfused compound. By contrast, thermolysis of the more flexible urethane afforded the desired cis fused product. The building blocks required for the synthesis of chelidonine are urathane and benzyl bromide. The urathane was obtained by first using nitrile, duo to hydrolysiscarboxylic acid was generated. The carboxylic acid which on Curtius degradation yielded crude isocyanate. The reaction of crude isocyanate with benzyl alcohol made the urethane, with the NHCOOC7H7 side group. The benzyl bromide was obtained by the conversion of 2,3-methylenedioxybenzaldehyde to 1,2,3,4 - tetrahydro-7,8-methylenedioxyisoquinol by the successive Hofmann and von Braun degradations. Condensation of urethane and benzyl bromide led to the formation of the oily styrene. From this structure the liquid acetylene was formed. Next, the crystalline tetrahydrobenzphenanthridine was formed. hydroboration and oxidation produced an alcohol. Jones oxidation gave rise to the ketone. And by processing the ketone the desired cis,cis-alcohol was formed. After hydrogenolysis of the benzyloxycarbonyl group, dl-norchelidonine was synthesized.
Available forms
Chelidonine has a few forms which are synthesized in a similar way and which are structurally alike, including: -homochelidonine, -chelamine and -norchelidonine are tertiary benzophenanthridine alkaloids with partially hydrogenated B and C rings. They occur in a number of plant species of the family Papaveraceae. The first two have been isolated from the roots of Chelidonium majus L. as minor alkaloids. Enantiomeric -norchelidonine has been recently found in C. majus.
Metabolism
Chelidonine is a major bioactive, isoquinoline alkaloid ingredient in Chelidonium majus. Benzylisoquinoline alkaloids are a structurally diverse group of plant specialized metabolites with a long history of investigation. A restricted number of enzyme families have been implicated in BIA metabolism. Whereas some enzymes exhibit a relatively broad substrate range, others are highly substrate specific. A small number of plant species, including opium poppy and other members of the Ranunculales, have emerged as model systems to study BIA metabolism. Recently, the emergence of transcriptomics, proteomics and metabolomics has expedited the discovery of new BIA biosynthetic genes. In general, methyltransferases of BIA metabolism accept a wide variety of alkaloid substrates with diverse backbone structures, with some showing more flexibility than others with respect to substrate range.
Indications
Chelidonine is an isolate of Papaveraceae with acetylcholinesterase and butyrylcholinesterase inhibitory activity. AChE inhibitors or anti-cholinesterases inhibit the enzyme cholinesterase from breaking down ACh, increasing both the level and duration of the neurotransmitter action. According to the mode of action, AChE inhibitors can be divided into two groups: irreversible and reversible. Reversible inhibitors, competitive or noncompetitive, mostly have therapeutic applications, while toxic effects are associated with irreversible AChE activity modulators. Reversible AChE inhibitors play an important role in pharmacological manipulation of the enzyme activity. These inhibitors include compounds with different functional groups, and have been applied in the diagnostic and/or treatment of various diseases such as: myasthenia gravis, AD, post-operative ileus, bladder distention, glaucoma, as well as antidote to anticholinergic overdose.
Toxicity
Chelidonine has been studied in multiple organisms, but mainly in rats and mice. In these organisms, sublethal doses of chelidonine caused ptosis tremor, sedation, and a decrease in body temperature. The LD50 of chelidonine, intraperitoneally administered, is in mice 1.3 g/kg and in rats 2 g/kg. There are not many studies of toxicity of chelidonine in humans.
